{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:00:24Z","timestamp":1772215224434,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: HCMV causes severe clinical complications in transplant recipients and may lead to graft rejection. Successful renal transplantation heavily relies on the early prevention and diagnosis of CMV infections, followed by prompt prophylactic treatment before transplantation. Despite the majority of renal rejection cases with acute HCMV infections being asymptomatic and occurring one to two years later, the objective of this research was to comprehend the effect of late HCMV infection on renal rejection by examining specific clinical parameters in the Eastern Indian cohort. Method: In this study, 240 patients were studied for five years following transplantation, and their data were collected from the local metropolitan hospital in Eastern India. Both HCMV-positive and -negative post-transplant patients were investigated using the clinical parameters and viral loads for latent infection. Results: Within the studied population, 79 post-transplant patients were found to be HCMV positive. Among them, 13 (16.45%) patients suffered from renal rejection within less than 2 yrs. of transplantation (early rejection) and 22 (27.84%) patients suffered from renal rejection after 2 yrs. from the operation date (late rejection). Assessment of clinical parameters with respect to HCMV infection revealed that in early rejection cases, fever (p-0.035) and urinary tract infection (p-0.017) were prominent, but in late rejection, hematuria (p-0.032), diabetes (p-0.005), and creatinine level changes (p &lt; 0.001) were significant along with urinary tract infection (p-0.047). Conclusions: This study provides valuable insights into monitoring latent CMV infections and highlights the understanding of reducing renal rejection rates and the need for further research in this field.<\/jats:p>","DOI":"10.3390\/v16060847","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T10:14:07Z","timestamp":1716804847000},"page":"847","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Decade-Long Cohort Analysis of Human Cytomegalovirus (HCMV)-Induced Early and Late Renal Rejection in Post-Transplant Patients in the Eastern Indian Population"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5360-7995","authenticated-orcid":false,"given":"Debsopan","family":"Roy","sequence":"first","affiliation":[{"name":"Virus Research Laboratory, ICMR-National Institute of Cholera and Enteric Disease, Kolkata 700010, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aroni","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Biotechnology and Bioscience, Brainware University, Kolkata 700125, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atanu","family":"Pal","sequence":"additional","affiliation":[{"name":"Department of Nephrology, IPGME&R-SSKM, Kolkata 700020, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra Prasad","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Virus Research Laboratory, ICMR-National Institute of Cholera and Enteric Disease, Kolkata 700010, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilanjan","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Virus Research Laboratory, ICMR-National Institute of Cholera and Enteric Disease, Kolkata 700010, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.25122\/jml-2021-0209","article-title":"Cytomegalovirus infection after renal transplantation","volume":"15","author":"Tuama","year":"2022","journal-title":"J. Med. Life"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Selvey, L.A., Lim, W.H., Boan, P., Swaminathan, R., Slimings, C., Harrison, A.E., and Chakera, A. (2017). Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2599-y"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"bcr1220115314","DOI":"10.1136\/bcr.12.2011.5314","article-title":"Learning from errors: Incidence of CMV-HCV coinfection in renal transplant recipient","volume":"2012","author":"Chakraborty","year":"2012","journal-title":"BMJ Case Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcv.2007.10.006","article-title":"Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients","volume":"41","author":"Hughes","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/tri.12582","article-title":"Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: Case report and review of the literature","volume":"28","author":"Java","year":"2015","journal-title":"Transpl. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40620-020-00956-1","article-title":"Immunosuppression-related neurological disorders in kidney transplantation","volume":"34","author":"Faravelli","year":"2021","journal-title":"J. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.3748\/wjg.v26.i38.5797","article-title":"Gastrointestinal complications after kidney transplantation","volume":"26","author":"Gioco","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.21037\/tau.2018.08.11","article-title":"Neurologic complications of kidney transplantation","volume":"8","author":"Shoskes","year":"2019","journal-title":"Transl. Androl. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/tri.14122","article-title":"Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: A systematic review and network meta-analysis","volume":"34","author":"Ruenroengbun","year":"2021","journal-title":"Transpl. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0012.2010.01208.x","article-title":"The impact of cytomegalovirus infection \u22651 year after primary renal transplantation","volume":"24","author":"Browne","year":"2010","journal-title":"Clin. Transpl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients\u2014Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin. Transpl."},{"key":"ref_13","first-page":"2020","article-title":"Cytomegalovirus UL83 Gene as Diagnostic Marker for Preliminary Infection in Pregnant Women in AL-Najaf City","volume":"11","year":"2020","journal-title":"Syst. Rev. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/JVI.01251-08","article-title":"Human Cytomegalovirus Glycoprotein B Is Required for Virus Entry and Cell-to-Cell Spread but Not for Virion Attachment, Assembly, or Egress","volume":"83","author":"Isaacson","year":"2009","journal-title":"J. Virol."},{"key":"ref_15","unstructured":"Vaillant, A.A.J., Misra, S., and Fitzgerald, B.M. (2024, January 16). Acute Transplantation Rejection, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535410\/."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1432-2277.2000.tb01019.x","article-title":"Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: A cohort study with case-control analyses","volume":"13","author":"Toupance","year":"2000","journal-title":"Transpl. Int."},{"key":"ref_17","first-page":"e376","article-title":"Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets","volume":"7","author":"Bhatti","year":"2015","journal-title":"Cureus"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/00007890-199912270-00011","article-title":"Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients","volume":"68","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"ref_19","first-page":"CR609","article-title":"Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients","volume":"17","author":"Zelle","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.15171\/jrip.2016.18","article-title":"The effect of cytomegalovirus infection on acute rejection in kidney transplanted patients","volume":"5","author":"Hasanzamani","year":"2016","journal-title":"J. Ren. Inj. Prev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4285\/kjt.22.0001","article-title":"Laboratory diagnostic testing for cytomegalovirus infection in solid organ transplant patients","volume":"36","author":"Lee","year":"2022","journal-title":"Korean J. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1128\/JVI.02507-15","article-title":"Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells","volume":"90","author":"Humby","year":"2016","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1574-695X.2002.tb00598.x","article-title":"CD4+ T cell levels are decreased during active CMV infection in kidney transplant recipients","volume":"34","author":"Essa","year":"2002","journal-title":"FEMS Immunol. Med Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2215\/CJN.12691216","article-title":"Slow Rise in Serum Creatinine Level in a Kidney Transplant Recipient 3 Years Post-Transplant","volume":"12","author":"Bia","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/6\/847\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:48:50Z","timestamp":1760107730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/6\/847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["v16060847"],"URL":"https:\/\/doi.org\/10.3390\/v16060847","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,25]]}}}